Science & Enterprise subscription

Follow us on Twitter

  • Genny Cream for me, if I were there https://t.co/BQcWbr7yLh
    about 2 hours ago
  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 7 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 7 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 10 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago

Please share Science & Enterprise

Start-Up Designing Synthetic DNA for Gene Therapies

DNA puzzle

A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses. . . . → Read More: Start-Up Designing Synthetic DNA for Gene Therapies

Novavax Joins Alternative Second Shot Vaccine Trial

Syringes

Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations. . . . → Read More: Novavax Joins Alternative Second Shot Vaccine Trial

Infectious Disease Biotech Raises $100M in Venture Funds

Syringe and three vials

A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds

In-Body Gene Editing Tested as Sickle Cell Treatment

Crispr graphic

Tests with lab mice show the feasibility of editing genes in blood-forming stem cells in bone marrow as a potential treatment for sickle cell disease. . . . → Read More: In-Body Gene Editing Tested as Sickle Cell Treatment

Sensor in Works Detecting Covid-19 Airborne Virus

Graphene illustration

A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV-2 viruses in indoor air. . . . → Read More: Sensor in Works Detecting Covid-19 Airborne Virus

Novavax, J&J Return Mixed Covid-19 Vaccine Results

Syringe and three vials

Results from international clinical trials show largely favorable results for two Covid-19 vaccines, but still limitations against the South African variant. . . . → Read More: Novavax, J&J Return Mixed Covid-19 Vaccine Results

Simpler Method Devised to Validate Covid-19 Tests

Covid-19 testing

An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2 viruses responsible for Covid-19. . . . → Read More: Simpler Method Devised to Validate Covid-19 Tests

Nanoscale Particles Deliver Crispr Cancer Treatments

Crispr-Cas9 illustration

Researchers in Israel developed techniques to deliver gene editing therapies with lipid nanoscale particles that in lab mice killed cancer cells and increased survival. . . . → Read More: Nanoscale Particles Deliver Crispr Cancer Treatments

Blood Cells Transport Enzymes to Slow Cancer Spread

Red blood cells and nanoparticles

Researchers devised a technique that in lab mice carries immune system enzymes on red blood cells to stop the spread of cancer in the lungs. . . . → Read More: Blood Cells Transport Enzymes to Slow Cancer Spread

Start-Up Gains Drug Nanoparticle Manufacturing Tech

Small bubbles

A new enterprise spun-off from University of Connecticut is acquiring a technology for continuous manufacturing of nanoscale drug particles. . . . → Read More: Start-Up Gains Drug Nanoparticle Manufacturing Tech